Poster Presentation The 13th International Congress of the Immunology of Diabetes Society 2013

Low Dose of Rapamycin/IL-2 Treatment Protect Human Islet Allograft from Rejection in a Humanized Diabetic Mouse Model (#161)

Min Hu 1 , Wayne J HAWTHORNE 1 , Heather BURNS 1 , Hei NAN 1 , Jingjing WU 1 , Sussan DAVIES 1 , David LIUWANTARA 1 , Joanne HAWKES 1 , Yi Wen QIAN 1 , Lindy WILLIAMS 1 , Tina PATEL 1 , Elvira JIMENEZ-VERA 1 , Katie HOR 1 , Ya Wang 1 , Yuan Min WANG 2 , Geoff Y ZHANG 2 , Shounan YI 1 , Stephen I ALEXANDER 2 , Philip O'Connell 1
  1. Westmead Millennium Institute, University of Sydney, Westmead, NSW, Australia
  2. Centre for Kidney Research, Children's Hospital at Westmead, University of Sydney, Westmead, NSW, Australia
Publish consent withheld